miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell Stem Cell

• Publication date

  2010-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.stem.2010.11.010PMID 21112564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2009

  2010cited by this paper
• MicroRNA control of signal transduction

  2010cited by this paper
• Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• MicroRNAs: key regulators of stem cells

  2009cited by this paper
• Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma

  2009cited by this paper
• EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

  2009influential reference
• Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

  2009cited by this paper
• Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

  2009cited by this paper
• MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications

  2009cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• Molecular mechanisms of hepatocellular carcinoma

  2008cited by this paper
• Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

  2008cited by this paper
• CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway

  2008influential reference
• Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

  2008cited by this paper
• Significance of CD90+ cancer stem cells in human liver cancer.

  2008cited by this paper
• Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

  2008cited by this paper
• Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

  2008cited by this paper
• Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus

  2008cited by this paper
• Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1.

  2008cited by this paper
• Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

  2008cited by this paper
• Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

  2007influential reference
• DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper
• CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

  2007cited by this paper
• Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1

  2007cited by this paper
• Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

  2007cited by this paper
• let-7 regulates self renewal and tumorigenicity of breast cancer cells.

  2007cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma.

  2006cited by this paper
• Cancer stem cells.

  2006cited by this paper
• Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer.

  2006cited by this paper
• Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.

  2006cited by this paper
• Stem cell division is regulated by the microRNA pathway

  2005cited by this paper
• miRNAs, cancer, and stem cell division.

  2005cited by this paper
• Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• MicroRNAs: small RNAs with a big role in gene regulation

  2004cited by this paper
• Human embryonic stem cells express a unique set of microRNAs.

  2004cited by this paper
• MicroRNAs: small RNAs with a big role in gene regulation

  2004cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Dicer is essential for mouse development

  2003cited by this paper
• Dicer is essential for mouse development

  2003cited by this paper
• P53-dependent expression of the stress-induced protein (SIP).

  2002cited by this paper
• Molecular and Functional Characterization of the Stress-induced Protein (SIP) Gene and Its Two Transcripts Generated by Alternative Splicing

  2001cited by this paper
• Molecular and Functional Characterization of the Stress-induced Protein (SIP) Gene and Its Two Transcripts Generated by Alternative Splicing SIP INDUCED BY STRESS AND PROMOTES CELL DEATH*

  2001cited by this paper
• Self-assembly of mesoscopically ordered chromatic polydiacetylene/silica nanocomposites

  2001cited by this paper
• p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis.

  2001cited by this paper
• The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

  2000cited by this paper
• The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

  year unknowncited by this paper

• Emerging strategies in engineering nanomaterials for overcoming cancer stem cell-mediated therapy resistance

  2025cites this paper
• Role of miR-15b and miR-130b as Non-Invasive Biomarkers in Hepatocellular Carcinoma

  2025cites this paper
• Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors

  2025cites this paper
• Dual‐Targeted Nanovesicles Induced Cancer Stem‐Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy

  2025cites this paper
• Biomedical engineering targeting cancer stem cells to reinforce cancer therapy

  2025cites this paper
• Circulating Cancer Associated Fibroblast and Cancer Stem Cell Markers as Diagnostic and Prognostic Tools of Hepatitis C Induced Hepatocellular Carcinoma

  2025cites this paper
• Liver cancer stem cells as novel diagnostic biomarkers.

  2025cites this paper
• MiR-130b-3p Suppress the Migration, Proliferation and Chemosensitization of Hepatocellular Carcinoma Cells

  2024cites this paper
• Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)

  2024cites this paper
• METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation

  2024cites this paper
• Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma

  2024cites this paper
• LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT/β-catenin signaling

  2024cites this paper
• miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1

  2024cites this paper
• Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways

  2024cites this paper
• NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells

  2024cites this paper
• Targeting non-coding RNAs and N6-methyladenosine modification in hepatocellular carcinoma.

  2024cites this paper
• Redox regulation of cancer stem cells: Biology and therapeutic implications

  2024cites this paper
• Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction.

  2023cites this paper
• To be or not to be: The double-edged sword roles of liver progenitor cells.

  2023cites this paper
• Liver stiffness, hepatorenal index, and microRNA-130b as predictors for chronic kidney disease in patients with non-alcoholic fatty liver disease

  2023cites this paper
• SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma

  2023cites this paper
• SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling

  2023cites this paper
• MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcoma

  2023cites this paper
• Regulation of Inflammatory Cell Death by Phosphorylation

  2022cites this paper
• The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response

  2022cites this paper
• Role of genetic insights and tumor microenvironment in liver cancer: new opportunities for gene therapy

  2022cites this paper
• Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches.

  2022cites this paper
• Hepatocellular Carcinoma: The Role of MicroRNAs

  2022cites this paper
• Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

  2022cites this paper
• Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma

  2022cites this paper
• The expression of apoptosis related genes in HK-2 cells overexpressing PPM1K was determined by RNA-seq analysis

  2022cites this paper
• STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth

  2022cites this paper
• miR-3168 promotes hepatocellular carcinoma progression via downregulating p53.

  2022cites this paper
• Genetic heterogeneity of liver cancer stem cells

  2022cites this paper
• miR-6071 inhibits hepatocellular carcinoma progression via targeting PTPN11.

  2022cites this paper
• Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma

  2022cites this paper
• TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype

  2022cites this paper
• Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model

  2022cites this paper
• Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report.

  2021cites this paper
• A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment

  2021cites this paper
• Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers

  2021cites this paper
• Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression

  2021cites this paper
• Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications

  2021cites this paper
• Echinacoside Suppresses the Progression of Breast Cancer by Downregulating the Expression of miR-4306 and miR-4508

  2021cites this paper
• Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma

  2021cites this paper
• Regulators of liver cancer stem cells

  2021cites this paper
• The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers.

  2021cites this paper
• Chemotherapy‐Enriched THBS2‐Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications

  2021cites this paper
• RETRACTED ARTICLE: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas

  2021cites this paper
• The role of CD133 in hepatocellular carcinoma

  2021cites this paper
• MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3

  2021cites this paper
• The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells.

  2021cites this paper
• MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

  2021cites this paper
• Ascorbic Acid Inhibits Liver Cancer Growth and Metastasis in vitro and in vivo, Independent of Stemness Gene Regulation

  2021cites this paper
• Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells

  2021cites this paper
• Prevalence of copy number variants (CNVs) and rhGH treatment efficacy in an Italian cohort of children born small for gestational age (SGA) with persistent short stature associated with a complex clinical phenotype

  2021cites this paper
• Downregulated microRNA-130b-5p Prevents Lipid Accumulation and Insulin Resistance in a Murine model of Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma

  2020cites this paper
• Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

  2020influential citation
• MiR130b from Schlafen4+ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer

  2020cites this paper
• KLF8 promotes cancer stem cell-like phenotypes in osteosarcoma through miR-429-SOX2 signaling.

  2020cites this paper
• The Cancer Stem Cell in Hepatocellular Carcinoma

  2020cites this paper
• CMAR_A_246311 3771..3782

  2020cites this paper
• Role of CD133 in human embryonic stem cell proliferation and teratoma formation

  2020cites this paper
• Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells

  2020cites this paper
• miRNAs and Hepatocellular Carcinoma

  2020cites this paper
• Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation

  2020cites this paper
• Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma

  2020cites this paper
• Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins

  2020cites this paper
• Secretory galectin-3 induced by glucocorticoid stress triggers stemness exhaustion of hepatic progenitor cells

  2020cites this paper
• Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer

  2020cites this paper
• Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis

  2020cites this paper
• Liver cancer stem cells as a hierarchical society: yes or no?

  2020cites this paper
• A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma

  2020cites this paper
• Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies

  2020cites this paper
• Fate and functional roles of Prominin 1+ cells in liver injury and cancer

  2020cites this paper
• miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A

  2020cites this paper
• miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance

  2020cites this paper
• A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells

  2020cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• Micromanaging aerobic respiration and glycolysis in cancer cells

  2019cites this paper
• Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.

  2019cites this paper
• RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog

  2019cites this paper
• MicroRNA-9-5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway

  2019cites this paper
• Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma

  2019cites this paper
• Molecular Diagnostic in Prostate Cancer

  2019cites this paper
• Cellular Origin of Hepatocellular Carcinoma

  2019influential citation
• Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment

  2019cites this paper
• Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models

  2019cites this paper
• Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma

  2019cites this paper
• TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p

  2019cites this paper
• The Phosphatidylethanolamine Biosynthesis Pathway Provides a New Target for Cancer Chemotherapy.

  2019cites this paper
• The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma

  2019cites this paper
• Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells

  2019cites this paper
• Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1

  2019cites this paper
• Nanomedicinal delivery systems for intelligent treatment of hepatocellular carcinoma

  2019cites this paper
• The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets.

  2019cites this paper
• Advances in surface markers of liver cancer stem cell

  2019cites this paper
• Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

  2019cites this paper
• Mutual suppression between BHLHE40/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells

  2019cites this paper